Laurie E. Gaspar

1990–2025 年に発表

94
論文数
32,742
被引用数
80
h 指数
94
i10 指数

被引用数

Laurie E. Gaspar の年別被引用数1959 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 4 件1994 年: 被引用 7 件1995 年: 被引用 2 件1996 年: 被引用 9 件1997 年: 被引用 10 件1998 年: 被引用 10 件1999 年: 被引用 22 件2000 年: 被引用 27 件2001 年: 被引用 28 件2002 年: 被引用 48 件2003 年: 被引用 54 件2004 年: 被引用 57 件2005 年: 被引用 85 件2006 年: 被引用 93 件2007 年: 被引用 98 件2008 年: 被引用 118 件2009 年: 被引用 124 件2010 年: 被引用 200 件2011 年: 被引用 193 件2012 年: 被引用 197 件2013 年: 被引用 232 件2014 年: 被引用 247 件2015 年: 被引用 225 件2016 年: 被引用 238 件2017 年: 被引用 178 件2018 年: 被引用 228 件2019 年: 被引用 835 件2020 年: 被引用 1,055 件2021 年: 被引用 891 件2022 年: 被引用 663 件2023 年: 被引用 468 件2024 年: 被引用 759 件2025 年: 被引用 289 件2026 年: 被引用 7 件1960〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,378 件、この内訳の 28.6%中国: 引用元論文 698 件、この内訳の 8.4%カナダ: 引用元論文 539 件、この内訳の 6.5%ドイツ: 引用元論文 494 件、この内訳の 5.9%イタリア: 引用元論文 478 件、この内訳の 5.7%オランダ: 引用元論文 379 件、この内訳の 4.6%イギリス: 引用元論文 332 件、この内訳の 4%フランス: 引用元論文 322 件、この内訳の 3.9%日本: 引用元論文 306 件、この内訳の 3.7%スイス: 引用元論文 285 件、この内訳の 3.4%スペイン: 引用元論文 235 件、この内訳の 2.8%オーストラリア: 引用元論文 191 件、この内訳の 2.3%
0%28.6%その他 20.2%

分野

  • Medicine86.6%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Physics and Astronomy4.6%
  • Neuroscience0.8%
  • Engineering0.8%
  • Immunology and Microbiology0.5%
  • その他1.2%

トピック

  • Brain Metastases and Treatment13.3%
  • Lung Cancer Research Studies9.4%
  • Lung Cancer Treatments and Mutations8.8%
  • Lung Cancer Diagnosis and Treatment7.7%
  • Glioma Diagnosis and Treatment7.3%
  • Advanced Radiotherapy Techniques5.1%
  • その他48.4%

共著者

全論文

検索で開く
  1. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 798

  2. Response assessment criteria for brain metastases: proposal from the RANO group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 1,088

  3. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 1,270

  4. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 1,086

  5. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, Yi An, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - Journal of Clinical Oncology 2020 被引用: 467

  6. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 455

  7. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 548

  8. Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 1,420

  9. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

    著者: , , , , , , , , , , , , , - The Lancet 2004 被引用: 2,426

  10. Estimating Survival in Patients With Lung Cancer and Brain Metastases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2016 被引用: 658

  11. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 301

  12. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , - Journal of Thoracic Oncology 2012 被引用: 677

  13. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

    著者: , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1997 被引用: 2,556

  14. Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

    著者: , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2009 被引用: 985

  15. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 100

  16. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 96

  17. A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database

    著者: , , , , - International Journal of Radiation Oncology*Biology*Physics 2007 被引用: 1,043

  18. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

    著者: , , , , , , , , , , , , , - Practical Radiation Oncology 2012 被引用: 590

  19. Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial Plexus

    著者: , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2010 被引用: 391

  20. Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yi An, Veronica Chiang, Liang Zeng, Hany Soliman, Hesham Elhalawani, Daniel Cagney, Evan Thomas, Drexell H. Boggs, Manmeet S. Ahluwalia, Minesh P. Mehta - International Journal of Radiation Oncology*Biology*Physics 2022 被引用: 120

  21. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

    著者: , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 1,095

  22. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 804

  23. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 384

  24. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

    著者: , , , , , , , , , , , , , , , , , - Journal of Neuro-Oncology 2009 被引用: 351